Absence of Both Cytochrome P450 3A and P-glycoprotein Dramatically Increases Docetaxel Oral Bioavailability and Risk of Intestinal Toxicity

R.A. van Waterschoot, J.S. Lagas, E. Wagenaar, C.M.M. Van der Kruijssen, A.E. van Herwaarden, J.Y. Song, R.W. Rooswinkel, O. van Tellingen, H. Rosing, J.H. Beijnen, A.H. Schinkel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)8996-9002
Number of pages7
JournalCancer Research
Volume69
Publication statusPublished - 2009

Cite this